Small intestine hexose transport in experimental diabetes: Increased transporter mRNA and protein expression in enterocytes by Burant, C.F. et al.
Small intestine hexose transport in
experimental diabetes. Increased transporter
mRNA and protein expression in enterocytes.
C F Burant, … , J B Buse, E B Chang
J Clin Invest. 1994;93(2):578-585. https://doi.org/10.1172/JCI117010.
The effect of insulinopenic diabetes on the expression of glucose transporters in the small
intestine was investigated. Enterocytes were sequentially isolated from jejunum and ileum
of normal fed rats, streptozotocin-diabetic rats, and diabetic rats treated with insulin.
Facilitative glucose transporter (GLUT) 2, GLUT5, and sodium-dependent glucose
transporter 1 protein content was increased from 1.5- to 6-fold in enterocytes isolated from
diabetic animals in both jejunum and ileum. Insulin was able to reverse the increase in
transporter protein expression seen after induction of diabetes. There was a four- to
eightfold increase in the amount of enterocyte glucose transporter mRNA after diabetes with
greater changes in sodium-dependent glucose transporter 1 and GLUT2 than in GLUT5
levels. In situ hybridization showed that after the induction of diabetes there was new
hybridization in lower villus and crypt enterocytes that was reversed by insulin treatment.
Thus, the increase in total hexose transport caused by diabetes is due to a premature
expression of hexose transporters by enterocytes along the crypt-villus axis, causing a
cumulative increase in enterocyte transporter protein during maturation. These changes are
likely to represent an adaptive response by the organism to increase nutrient absorption in a
perceived state of tissue starvation. These adaptive changes may lead to exacerbation of
hyperglycemia in uncontrolled diabetes.
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Abstract
The effect of insulinopenic diabetes on the expression of glu-
cose transporters in the small intestine was investigated. Enter-
ocytes were sequentially isolated from jejunum and ileum of
normal fed rats, streptozotocin-diabetic rats, and diabetic rats
treated with insulin. Facilitative glucose transporter (GLUT)
2, GLUT5, and sodium-dependent glucose transporter 1 pro-
tein content was increased from 1.5- to 6-fold in enterocytes
isolated from diabetic animals in both jejunum and ileum. Insu-
lin was able to reverse the increase in transporter protein ex-
pression seen after induction of diabetes.
There was a four- to eightfold increase in the amount of
enterocyte glucose transporter mRNAafter diabetes with
greater changes in sodium-dependent glucose transporter 1 and
GLUT2 than in GLUT5 levels. In situ hybridization showed
that after the induction of diabetes there was new hybridization
in lower villus and crypt enterocytes that was reversed by insu-
lin treatment.
Thus, the increase in total hexose transport caused by dia-
betes is due to a premature expression of hexose transporters
by enterocytes along the crypt-villus axis, causing a cumulative
increase in enterocyte transporter protein during maturation.
These changes are likely to represent an adaptive response by
the organism to increase nutrient absorption in a perceived
state of tissue starvation. These adaptive changes may lead to
exacerbation of hyperglycemia in uncontrolled diabetes. (J.
Clin. Invest. 1994. 93:578-585.) Key words: glucose transport
diabetes * intestine * fructose * gene regulation
Introduction
Small intestinal epithelial cells have a major role in the diges-
tion and absorption of dietary carbohydrates, which begins
with the hydrolysis of complex carbohydrates to monosaccha-
rides. The latter are then absorbed by the epithelium by both
energy-requiring and energy-independent mechanisms (1).
One of these processes involves the sodium-dependent glucose
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cotransporter (SGLT 1)' located at the brush border mem-
brane (BBM) that initiates the uptake of glucose, a highly effi-
cient process because of its coupling with the inwardly directed
sodium gradient of the cell (2). Effilux of hexoses from the
enterocyte occurs via a member of the facilitative glucose trans-
porter gene family (GLUT2) which has been localized by im-
munohistochemistry to the basolateral membrane of entero-
cytes (3). GLUT2has a low affinity for glucose (4), but under
conditions of active glucose transfer across the BBMthe kinetic
properties of GLUT2 allow for the efficient, unidirectional
movement of glucose out of the enterocyte into the interstitial
space and blood stream. Fructose, another major dietary sugar,
is transported by a carrier distinct from SGLT1 since muta-
tions in SGLT1 do not affect fructose transport (5) and dietary
manipulations that affect glucose flux do not affect fructose
flux (6). Recently, we have presented evidence that GLUT5 is
a high affinity fructose transporter of the BBM(7, 8). Addi-
tionally, we (4) and others (9) have shown that GLUT2 has
fructose transport activity and likely mediates the basolateral
exit of fructose from the enterocyte.
Hexose transport by the small intestine is modulated dur-
ing development and under different physiological states. For
instance, the intestinal uptake of both glucose and fructose
changes with the developmental age of the rat, independent of
diet ( 10). In contrast, adult rats fed diets enriched in glucose
show a specific upregulation of glucose transport activity in
both the BBM( 11) and the basolateral membrane ( 12). Re-
cently, changes in the BBMtransport activity were shown to be
due in part to increased sodium-dependent glucose transporter
expression in enterocytes emerging from the crypt regions of
the small intestinal mucosa ( 13).
Insulinopenic diabetes is another condition that may alter
intestinal glucose transport, as well as other digestive and nutri-
tive processes. Besides hypertrophy of specific mucosal regions,
there are alterations in hydrolases and water, electrolyte, and
nutrient absorption ( 14, 15). Glucose absorption is increased
in both the BBMand in the basolateral membranes of the en-
terocyte ( 15-17). Using the photolabel [3H ]phlorizin, which
preferentially labels the sodium-dependent glucose trans-
porter, Fedorak et al. ( 16) showed a significant increase in the
number of these transporters in the BBMof lower villus and
crypt enterocytes. This increase paralleled the increase in trans-
port activity which was increased in the crypt regions to a
greater extent than the villus tip regions. Insulinopenic diabetes
also increases basolateral membrane glucose transport as deter-
mined by uptake and cytochalasin B binding studies, the latter
1. Abbreviations used in this paper: BBM, brush border membrane;
GAPDH,glyceraldehyde 3-phosphate dehydrogenase; GLUT, facilita-
tive glucose transporter; SGLT, sodium-dependent glucose trans-
porter.
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a reagent that specifically labels facilitative glucose transporters
( 17 ). A recent report using human glucose transporter cDNA
probes has shown increased levels of GLUT2 and SGLT1
mRNAby RNAblotting mucosal scrapings of chronically dia-
betic rats ( 18).
Wehave recently cloned the rat homologues of GLUT5(8)
and SGLT1 (Lee, W.-S., Y. Kanai, R. G. Wells, and M. He-
diger, manuscript submitted for publication) which have al-
lowed the development of antisera specific for these transport-
ers. In this report, we use the specific rat cDNAsand antisera to
investigate the region-specific responses and the molecular
mechanisms responsible for the increase in glucose transport
after the induction of insulinopenic diabetes.
Methods
Animals. Male Sprague-Dawley rats (Charles River Breeding Laborato-
ries, Inc., Wilmington, MA) weighing 200-220 g were used in all exper-
iments. They were kept in a 12-h light/dark cycle and were fed a stan-
dard chow diet ad lib. except for a 12-h fast before injection of strepto-
zotocin. The protocol for the studies was approved by the Animal
Resource Center at the University of Chicago. Diabetes was induced by
intravenous injection of 50 mg/kg of streptozotocin. Blood glucose
was checked daily, and only those animals whose readings were > 300
mg/dl were considered diabetic. Some streptozotocin-diabetic rats
were treated with insulin (Novolin 70/30; Novo Nordisk, Copenha-
gen, Denmark) 6 wk after the induction of diabetes by subcutaneous
injection of insulin at - 20 U/kg twice daily for 1 wk. This regimen
nearly normalized blood glucose and allowed the diabetic rats to regain
weight at a rate similar to controls. The rats were killed 45 d after the
induction of diabetes or after 1 wk of insulin injections. Characteristics
of the experimental animals are presented in Table I.
Tissue preparation. Rats were anesthetized by intraperitoneal injec-
tion of chloral hydrate (700 mg/kg). The small intestine was removed
from Treitz's ligament to the cecum and was divided into thirds. The
proximal one-third was designated jejunum, and the distal one-third
was designated ileum as described previously ( 19). A 5-1 0-mmsection
of each segment was fixed for in situ hybridization, and the rest of the
intestine was used for isolation of enterocytes.
Enterocyte fractionation ofjejunium and iletim. A modification of
the procedure of Weiser (20) was used. Briefly, intestinal segments
were filled with 20 mMEDTA, 1 mMdithiothreitol, and 0.05% (vol/
vol) mercaptoethanol in PBS ( 15.2 mMNa2HPO4, 4.4 mMKH2PO4,
and 140 mMNaCl, pH 7.4) and were incubated at 37°C in PBSwith 20
mMEDTA. Fractions were isolated after sequential 7-min incubation
periods, except for the final fraction which was incubated for 10 min
followed by gentle massage to ensure complete removal of crypt cells.
At the end of each period, loops were emptied and flushed to obtain
Table I. Clinical Parameters of Control and Diabetic Rats
Weight Weight Blood
start end glucose Glycohemoglobin
g g mg/dl %
Control 272±8 386±11 121±7 6.1±0.9
Diabetes 278±10 235±15* >400* 13.8±2.9*
Insulin-treated 268±15 271±7* 169±21* ND
Diabetes was induced by administration of streptozotocin (50 mg/kg
body wt), and tissues were harvested after 45 d or after an additional
week of insulin treatment. Glucose concentration and glycohemoglo-
bin levels at the time of tissue harvest were determined by blood
obtained from cardiac puncture. Values shown are mean±SE for 4-10
animals. ND, not determined. * P < 0.05 vs control. t P < 0.05 vs
control and diabetic.
each fraction. Isolated cells were centrifuged at 1,500 g for 2 min and
were resuspended in PBSwith protease inhibitors (10Iug/ml leupeptin,
and 0.01% soybean trypsin inhibitor). Aliquots were processed for en-
zyme assays or RNAextraction, as described below. As described in the
past ( 19), reciprocal gradients of sucrase activities were obtained in
villus-to-crypt enterocyte fractions performed as described previously
(21 ) and corresponded to sucrose and [3H ] thymidine incorporation
gradients previously reported ( 19) (results not shown).
RNA isolation. RNAwas prepared immediately from 75% of the
cells isolated from each enterocyte fraction by homogenization in 7 M
guanidium thiocyanate, 0.5% N-lauryl sarcosine, and 25 mMsodium
citrate, pH 7.0. The RNAwas isolated by centrifugation through a
cushion of CsCl (21). Poly(A)+ mRNAwas prepared by oligo dT
chromatography and was quantitated by reading absorbance at 260
and 280 nm.
Northern blotting. 4-5 jig of poly(A)+ mRNAfrom each entero-
cyte fraction was subjected to 1%agarose /6% formaldehyde electropho-
resis and then was transferred to a nitrocellulose membrane by capil-
lary action. The blots were incubated with 32P-labeled-cDNA probes
corresponding to rat SGLT1 (Hediger, M. et al., unpublished results),
rat GLUT5 (8), or an 1,800-bp rat GLUT2 EcoRI fragment isolated
from a rat liver cDNA library prepared as previously described (8).
The membranes were washed in 0.1 x SSC, 0.1% SDS for 30 min at
25°C and then for 30 min at 56°C and were autoradiographed for
varying times for subsequent quantitation. Each blot was additionally
probed with a glyceraldehyde 3-phosphate dehydrogenase (GAPDH)
cDNA (American Type Culture Collection, Rockville, MD), a consti-
tutively expressed transcript, to normalize for loading of the gels (see
Results).
Total membrane isolation. One-quarter of each enterocyte fraction
was homogenized in 5 ml 10 mMTris, pH 7.4,250 mMsucrose, I mM
EDTA, I mMPMSF, and 1 gg/ml each leupeptin and pepstatin, and
was centrifuged at 900 g for 10 min. The resulting pellet was rehomo-
genized and recentrifuged as above. The supernates were combined
and centrifuged at 100,000 g for 75 min. The pellet was solubilized in
100-200 ,ul of the above buffer containing 0.5% deoxycholate and 0.5%
Triton X-100.
Western blotting. 100 1Ag of membrane protein was subjected to
SDS-PAGEusing a 10% resolving gel, and the proteins were electropho-
retically transferred to Immobilon-P membranes (Millipore Corp.,
Bedford, MA). The filters were blocked with 5% Carnation Instant
Milk® in Tris-buffered saline (20 mMTris, pH 7.4, 50 mMNaCl, and
0.05% Tween 20) and were probed with antisera specific for the glucose
transporter of interest. After washing three times in 50 ml Tris-buffered
saline, the blots were developed by the addition of '251I-labeled protein
A (Amersham Corp., Arlington Heights, IL) and were autoradio-
graphed for various periods of time to attain images within the linear
range of the autoradiographic film (Kodak XAR; Eastman Kodak Co.,
Rochester, NY) before subsequent quantitation. Rat GLUT2antisera
was obtained from East Acres Biologicals (Southbridge, MA), lot
160708. ratGLUT5 antisera was produced by injection of synthetic
peptides corresponding to the last 17 amino acids of the predicted rat
GLUT5 sequence, EKEEKELNDLPPATREE(8), into rabbits after
emulsification in Freund's adjuvant and was a gift of Dr. Sam Cush-
man (National Institutes of Health, Bethesda, MD). The rat SGLT1
antibodies were raised against a peptide, KPIPDVHLYRLCWSL-
RNST, that corresponds to amino acids 550-567 of the predicted pro-
tein sequence of rat SGLT1 (Lee, W.-S., Y. Kanai, R. G. Wells, and M.
Hediger, manuscript submitted for publication) and were prepared by
a commercial source (Research Genetics, Huntsville, AL). The speci-
ficity of the latter two antisera was determined by the ability of the
immunizing peptide to eliminate signal on Western blots and by the
ability of the antisera to specifically immunoprecipitate rat GLUT5
and rat SGLT1 protein synthesized using transporter mRNAin a rab-
bit reticulocyte lysate (data not shown).
Quantitation of-glucose transporter mRNAand protein content. The
autoradiographs were scanned with a Scan Jet Ilc (Hewlett-Packard
Co., Palo Alto, CA) at 400 dots per inch resolution and the images were
analyzed (Image 1.42 program; National Institutes of Health) using a
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256 gray scale image. RNAand protein samples from control and dia-
betic animals, as well as insulin-treated animals where appropriate,
were simultaneously electrophoresed and probed with labeled cDNA
or antisera on the same blot.
In situ hybridization. In situ hybridization was performed as de-
scribed previously (8). The synthetic RNAwas prepared from a 486-
bp EcoRI fragment of GLUT5, a 71 8-bp EcoRI/HindIII fragment of
GLUT2, or a 550-bp BamHI fragment of SGLTI after subcloning into
pGEM4Zand was linearized with an appropriate restriction enzyme.
The subsequent sense or antisense synthetic RNAs were transcribed
using SP6 or T7 RNApolymerase in the presence of a35S-UTP (8).
Samples from control, diabetic, and insulin-treated rats were mounted
on the same slide and were probed simultaneously.
Statistical analysis. Differences between groups were determined
by Student's t test with significance taken as P < 0.05.
Results
Clinicalfeatures of rats. Rats were treated with streptozotocin
and were maintained for 6 wk in a protocol we have used previ-
ously to study the effect of chronic diabetes on intestinal func-
tion ( 19). Progressive weight loss was seen in the rats treated
with streptozotocin (Table I). This was accompanied by hyper-
glycemia and elevated glycosylated hemoglobin levels. In pre-
vious studies from this laboratory, streptozotocin-diabetic rats
prepared under the same protocol had insulin levels that were
below the limit of detection. Diabetic rats that were treated
with insulin nearly normalized their blood glucose levels (Ta-
ble I) and initiated weight gain at a rate comparable with con-
trol (not shown).
Expression of glucose transporters in fractionated entero-
cytes. Incubation of small intestinal segments in an EDTA-
containing buffer results in the progressive removal of entero-
cytes from villus to crypts. Gradients of sucrase-isomaltase and
thymidine incorporation are obtained using this method ( 19),
but because of admixing of fractions it provides a qualitative
difference in the expression of macromolecules along the crypt-
villus axis. The amount of glucose transporter protein ex-
pressed in the enterocytes was quantitated by SDS-PAGE.
Identical amounts of total, post-nuclear membrane protein
from enterocyte fractions from jejunum and ileum were sub-
jected to Western blot analysis using specific anti-glucose trans-
porter antibodies. The GLUT2 antisera has been previously
characterized and recognizes a band of 60-62 kD. The rat
GLUT5 and rat SGLT1 antisera recognize proteins of 57-60
and 70-72 kD, respectively (Fig. 1, insets). Detection of these
bands by both antisera can be eliminated by preincubation
with the immunizing peptide. For each ofthe glucose transport-
ers, there was more immunoreactive protein isolated from je-
junum compared with ileum (Fig. 1, insets). Enterocyte frac-
tionation from control intestine showed a slightly greater
amount of GLUT2and GLUT5protein in the mid and upper
villus fractions as compared with crypt fractions, but these
changes were not significantly different. SGLT1 protein ex-
pression appeared more evenly distributed along the villus-
crypt axis (Fig. 1 C).
Glucose transporter protein levels are increased in diabetic
rats and are reversed by insulin treatment. Hypertrophy of the
gastrointestinal tract in diabetic rats is accompanied by a 40
and 10% increase in total enterocyte protein isolated from dia-
betic jejunum and ileum, respectively. However, there is no
difference in the amount of protein recovered per DNAcon-
tent of the enterocyte fractions ( 17, and Chang, E. B., manu-
script in preparation) . Although total post-nuclear membrane
protein recovered was increased in the diabetic samples, there
was no change in the total membrane protein recovered per
milligram of homogenate protein (Table II). Insulin treatment
of diabetic animals likewise had no effect on the recovery of
membrane protein (Table II).
Streptozotocin-induced diabetes resulted in a significant in-
crease in the amount of GLUT2 protein expressed in both
jejunal and ileal enterocytes (Fig. 1 A). The largest relative
increase was seen in the fractions derived from the lower villus
and crypt in both the jejunum and ileum with up to sixfold
more protein expressed in these fractions. Because of the lower
basal levels of GLUT2 expression in the ileum, the fold in-
crease was slightly greater in magnitude in the ileum than in the
jejunum (Fig. 1, A vs B), but the absolute amount of GLUT2
protein was still less in ileal as compared with jejunal entero-
cytes (Fig. 1, A and B, insets).
The expression of GLUT5 protein in the same enterocyte
fractions was also increased by diabetes (Fig. 1, C and D).
Again, the increase was more marked in the samples from the
crypt as opposed to the villus tip, and, as with GLUT2, there
was on average a greater amount of GLUT5 in the jejunum
than in the ileum with up to a fourfold increase in GLUT5
protein in the crypt fractions (Fig. 1, Cand D). The change in
expression of SGLT1 in these samples was more variable after
the induction of diabetes, with a much greater change seen in
jejunum as compared with ileum. However, there was a signifi-
cant increase in the content of SGLT1 protein in the ileal crypt
fraction as well as in all jejunal fractions.
Insulin treatment of the rats markedly improved blood glu-
cose levels (Table II) and resulted in less total protein from
each enterocyte fraction as compared with control (not
shown). A reduction in the amount of immunoreactive
GLUT2, GLUT5, and SGLT1 to near control levels was seen
per milligram of post-nuclear membrane protein in the jejunal
and ileal fractions from the insulin-treated diabetic rats
(Fig. 2).
Glucose transporter mRNAis increased in diabetes. To ex-
amine the mechanism responsible for increased glucose trans-
porter protein expression in diabetic rats, total cellular RNA
was prepared from the enterocyte fractions and was enriched
for poly(A)+ mRNAby oligo dT chromatography. In these
experiments, six fractions of enterocytes were isolated. The
amount of total RNA recovered per cell protein was un-
changed after the induction of diabetes (Table II). To normal-
ize for slight differences in the poly(A)+ mRNAloaded in each
lane, each Northern blot was probed with 32P-labeled GAPDH
cDNA. Although GAPDHlevels rose approximately twofold
per microgram of poly(A)+ RNAafter the induction of dia-
betes, similar amounts were expressed in each of the enterocyte
fractions from jejunum and ileum per microgram of RNA
loaded on the gel (Fig. 3). The data for the subsequent North-
ern blots were normalized within each fractionation experi-
ment to GAPDHmRNAlevels, that is, the amount of glucose
transporter mRNAdetected was first divided by the amount of
GAPDHdetected in the same sample. The calculated amount
in each diabetic sample was then divided by the calculated
amount in the control sample within each of the crypt-to-villus
fractions to arrive at the relative amount of diabetic/control
mRNA.Although this correction will decrease relative changes
in the diabetic samples as compared with control, it increases
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Figure 1. Effect of diabetes on glucose transporter protein expression in enterocytes. Enterocytes were sequentially isolated from villus tip to
crypt, and 100 ,4g of total post-nuclear membrane protein was isolated and separated by SDS-PAGEas described in Methods. Relative amount
of immunoreactive protein, GLUT2 (A and B), GLUT5 (C and D), and SGLT1 (E and F) from jejunum (A, C, and E) or ileum (B, D, and
F) in enterocyte fractions from control o and diabetic rats. Each bar represents the mean ±SE from three to four determinations from indi-
vidual animals. *Significant differences between control and diabetic samples at P < 0.05. (Insets) Representative autoradiograph of GLUT2,
GLUT5, or SGLT1 protein from the fractionated small intestinal segments isolated from control and diabetic animals.
the accuracy of quantitation. To eliminate intraassay variabil-
ity, control- and diabetic-derived RNApreparations from each
set of rats in an experiment were chromatographed on the same
gel, were transferred to the same piece of nitrocellulose, and
were probed sequentially for each transporter as well as for
GAPDHmRNA.
Table II. Effect of Diabetes and Insulin Treatment on Protein and RNALevels
Total membrane protein BBMprotein RNA
Homogenate protein Total membrane protein Homogenate protein
Jejunum Ileum Jejunum Ileum Jejunum Ileum
Cog 11g Mg
Control 0.19±0.05 0.21±0.11 0.076±0.012 ND 17.6±5.9 21.1±12.8
Diabetes 0.22±0.09 0.16±0.08 0.083±0.009 ND 13.4±4.3 16.9±7.2
Insulin-treated diabetic 0.21±0.04 0.16±0.11 0.078±0.21 ND ND ND
Total cellular membranes, BBM, and total cellular RNAwere isolated from jejunal and ileal enterocytes as described in Methods. The values
shown are the mean±SE of the enterocyte fractions from three to four individual animals in each group. ND, not determined.
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Figure 2. Effect of insulin on glucose transporter expression in diabetic rat jejunum. After 45 d of diabetes, rats were treated for 1 wk with twice
daily injections of insulin, resulting in near normalization of blood glucose. Relative amounts of immunoreactive protein of the enterocyte
fractions from control u, diabetic ., and insulin-treated diabetic o rats. Shown is the mean of two experiments. (Insets) Representative autora-
diograph of GLUT2, GLUT5, or SGLT1 protein from the fractionated small intestinal segments isolated from control, diabetic, and insulin-
treated diabetic animals.
Only a single transcript for each transporter was detected in
RNAfrom both control and diabetic intestine. WhenNorthern
blots were probed with 32P-labeled cDNAs, the relative size of
the GLUT2, GLUT5, and SGLT1 transcripts were 2.8, 3.2,
and 4.3 kb, respectively. As with the glucose transporter pro-
teins, in control animals there was more GLUT2 mRNAin
jejunal- than in ileal-derived enterocytes (Fig. 3). After induc-
tion of diabetes, there was a marked increase in the amount of
these transporter mRNAs, with a greater relative increase in
the enterocytes from the crypt compared with the villus cells
(Figs. 3 and 4). The increase in mRNAwas approximately
twofold for each transporter in the fractions from the villus tip,
with the exception of GLUT5 in jejunum which increased to
four- to eightfold in the crypt fractions. The increases in
mRNAfor the most part paralleled the increases seen in pro-
tein expression. There were increases in both jejunum and
ileum; the changes were greater for GLUT2 and SGLTI and
smaller for GLUT5, and the increases in glucose transporter
expression were seen in both jejunum and ileum. The largest
increases were in GLUT2and SGLT1 mRNAin both jejunum
and ileum with a much smaller rise in the relative amount of
GLUT5mRNA(Figs. 3 and 4).
In situ hybridization. To confirm the observed increase and
altered distribution of transporter mRNAexpression after the
induction of diabetes, we performed in situ hybridization stud-
ies on jejunal sections from control, diabetic, and insulin-
treated diabetic animals. Sections from each experimental
group were mounted on the same slide, and hybridization,
washing, and development were performed together. As shown
previously for GLUT5(8), the expression of both GLUT2and
GLUT5 mRNAsbegins to appear in enterocytes emerging
from the crypts, is highest in the midvillus regions, and de-
creases at the villus tip (Fig. 5). By contrast, SGLT1 is more
evenly distributed in the bottom two-thirds of the villus with
decreasing amounts in the villus tip. There was negligible signal
within the crypts for any probe.
Although not quantitative, in the section from the diabetic
animals there appeared to be an increase in GLUT2, GLUT5,
and SGLT1 hybridization signal with a consistent pattern of
earlier expression in the crypt-villus axis. This was particularly
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Figure 3. Northern blot of glucose
transporter and GAPDHmRNA.
Enterocytes from jejunum and
ileum of control and diabetic ani-
mals were sequentially isolated from
villus tip to crypt, and poly(A)
mRNAwas isolated, denatured, and
electrophoresed on
formaldehyde/agarose gels. After
transferring to nitrocellulose, the
filters were sequentially probed with
32P-labeled cDNAs corresponding
to GLUT2, GLUTS, and SGLTI as
indicated.
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Figure 4. Effect of diabetes on
the expression of glucose trans-
porter mRNA.Enterocytes from
jejunum (A, C, and E) and
ileum (B, D, and E) from con-
trol o and diabetic rats were
sequentially isolated from villus
tip to crypt as described in Fig.
3. The resultant autoradiograms
were quantitated by scanning
densitometry, and the relative
amount of transporter was deter-
mined after normalization of
each mRNAto GAPDHmRNA
within each experiment (see
Methods and Results). A and B,
GLUT2; Cand D, GLUT5; E
and F, SGLT1. Shown is the
mean±SE. n = 3-4 for each
point. *Significant increase in
diabetic above control mRNA
content at P < 0.05.
evident in GLUT2 and GLUT5 hybridizations (Fig. 5, B, E,
and H). The insulin-treated group tended to show an apparent
decrease in hybridization signal as compared with the diabetic
sections with each probe and an elimination of signal in the
lower villus and crypt regions seen in the diabetic jejunal sec-
tions (Fig. 5, C, F, and I).
Discussion
Diabetes is associated with hypertrophy of the small intestinal
villi of the proximal small intestine, which results in a greater
surface area for nutrient absorption in this state of relative tis-
sue starvation (21 ). The increase in surface area cannot en-
tirely account for the observed increases in glucose flux in the
small intestine of diabetic rats. There is a compensatory in-
crease in the amount of glucose flux on a per cell basis which
may account for 50-70% of the increase in glucose transport
( 16, 17). Studies of phloridzin binding suggested that part of
the increase is because of increased expression of sodium-de-
pendent glucose transporters in the crypt fractions of the villus
( 16). The experiments described here show that there is indeed
increased expression of SGLT protein in the cells isolated
from the crypt of both the jejunum and ileum.
In addition to increased glucose transport activity in the
BBMof diabetic animals, changes in glucose transport in the
basolateral membrane of both jejunal ( 17) and ileal entero-
cytes (22) have been noted. The increase in activity was great-
est in those enterocytes obtained from the lower villus and
crypt. In addition, after the induction of diabetes, there is an
increase in cytochalasin B binding, an antimetabolite that spe-
cifically inhibits facilitative glucose transport of the basolateral
membrane ( 17, 22). GLUT2 is the only facilitative glucose
transporter expressed in enterocytes (GLUT5 being a fructose
transporter), and there is a marked increase in the amount of
GLUT2protein expressed in all fractions of enterocytes in both
jejunum and ileum after the induction of diabetes, with the
largest increase being in enterocytes isolated from the crypt.
Thus, the increase in glucose flux across the enterocyte in strep-
tozotocin-induced diabetes is due to increases in SGLT ex-
pression at the BBMand GLUT2expression at the basolateral
membrane.
Recently, we have shown that GLUT5 is a fructose trans-
porter and have proposed that it is the primary fructose carrier
of the BBM(5, 8). Little is known about the changes in fruc-
tose transport in experimental or clinical diabetes, but the re-
sults presented here would suggest that, like glucose, the uptake
of fructose would be increased in insulinopenic diabetes.
The increase in both sodium-dependent and facilitative
glucose and fructose transporter protein levels seen after the
induction of streptozotocin diabetes is apparently due to in-
creased levels of mRNAin enterocytes in the villus-crypt axis
that normally express these transporters. In addition, diabetes
appears to change the pattern of expression of these genes along
the villus-crypt axis, with the expression of these genes begin-
ning to appear in relatively more immature cells of the lower
villus and crypt. These changes in expression were noted by
both RNAblotting of enterocyte fractions as well as by in situ
hybridization.
The increases in glucose transporter expression with dia-
betes can be reversed by insulin treatment of the diabetic ani-
mals (Figs. 2 and 5). Thus, the observed changes are not due to
a secondary effect of the streptozotocin. The mechanism by
which insulinopenic diabetes increases transporter expression
is not clear. Preliminary studies suggest that it is not simply
lack of insulin causing the change, since glucose infusion and
high carbohydrate feeding can increase facilitative glucose
transporter expression (Burant, C. F., manuscript in prepara-
tion). This would suggest that increased glucose, either in the
blood or intestine (secondary to hyperphagia associated with
diabetes), may increase in the transporter levels. Similarly,
high carbohydrate diets increase the expression of sodium-de-
pendent glucose transporters in the small intestine of mice with
the predominant increase in crypt enterocytes ( 11). In addi-
tion, it has been shown that both high carbohydrate diets and
glucose infusion can increase the transport activity in the baso-
lateral membrane in rat enterocytes ( 12). The mechanism by
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Figure 5. In situ hybridization of glucose
transporters in jejunum from control, diabetic,
and diabetic rats treated with insulin. Repre-
sentative dark-field photomicrographs of je-
junal sections hybridized with 35S-labeled
cRNA and developed 8 d later as described
previously (8). Sections of jejunum from con-
trol (A, D, G, and J), diabetic (B, E, H, and
K), and insulin-treated diabetic rats (C, F. I,
and L) hybridized with antisense SGLT1 (A,
B, and C), GLUT2(D, E, and F), GLUT5 (G,
H, and I) or a representative control, and sense
GLUT2 (J, K, and L) cRNA. Bar = 20 jiM.
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which increased loads of glucose to the enterocyte increases
expression of glucose transporter proteins is not clear.
The increase in facilitative glucose transporter levels in the
small intestine in response to insulinopenic diabetes is contrary
to reported observations in muscle and adipose tissue. A de-
crease in the insulin-responsive glucose transporter (GLUT4)
mRNAand/or protein has been observed after the induction
of diabetes (23, 24). In contrast, the levels of rat liver GLUT2
mRNAand protein levels have either been reported to rise
(25), have no change (26), or have a biphasic response to
streptozotocin-induced diabetes (27). The mechanism for tis-
sue differences in controlling transporter expression is not yet
understood.
In conclusion, we show at the molecular and cellular levels
that diabetes causes an increase in the levels of glucose (SGLT 1
and GLUT2) and fructose (GLUT5) transporters in the small
intestine. This is due, at least in part, to mechanisms that in-
clude induction of precocious expression of these genes in crypt
cells and increased mRNAand protein abundance by each
enterocyte. These increases in transporter expression may rep-
resent an adaptive mechanism by the organism to increase nu-
trient uptake in a time of relative tissue starvation. The increase
in absorptive capacity of the small intestine for carbohydrate
along with hyperphagia associated with uncontrolled diabetes
may lead to an exacerbation of the hyperglycemia seen in this
condition.
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